Home › Heart Diseases › Virginia › Richmond
Heart Diseases clinical trials in Richmond, VA
4 studies for Heart Diseases are looking for participants at sites in and around Richmond (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- Virginia Commonwealth University, Richmond
Transition to KPL-387 Monotherapy Dosing & Administration Study
RecruitingPhase 2
- Investigational Site 008, Richmond
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- Virginia Commonwealth University, Richmond
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- HCA Chippenham Medical Center, Richmond
About Heart Diseases
Heart disease is the leading cause of death in the U.S. Learn about the different types of heart diseases, and what you can do to try to prevent them.
More about Heart Diseases on MedlinePlus
Heart Diseases trials in other cities
- New York City, NY17 studies
- Boston, MA13 studies
- Dallas, TX12 studies
- Cleveland, OH12 studies
- Los Angeles, CA11 studies
- Philadelphia, PA11 studies
- Portland, OR10 studies
- Pittsburgh, PA10 studies
- Durham, NC10 studies
- Rochester, MN10 studies
- Indianapolis, IN10 studies
- St. Louis, MO9 studies
Other studies in Richmond
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Prostate Cancer19 studies
- Heart Failure17 studies
- Lung Cancer15 studies
- Cardiovascular Disease13 studies
- Head and Neck Squamous Cell Carcinoma13 studies
- Colorectal Cancer13 studies
- Cancer (all types)12 studies
- Metastatic Cancer12 studies
- Diffuse Large B-Cell Lymphoma11 studies
- Steatotic Liver Disease11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.